|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:atccode
|
C07 AB07
|
|
gptkbp:brand
|
gptkb:Lopressor
gptkb:Seloken
|
|
gptkbp:clinical_trial
|
Phase III
|
|
gptkbp:contraindication
|
Asthma
Heart block
Severe bradycardia
|
|
gptkbp:dosage_form
|
Extended-release tablet
Immediate-release tablet
|
|
gptkbp:duration
|
Short-term
Long-term
|
|
gptkbp:effective_date
|
gptkb:1978
|
|
gptkbp:excretion
|
Urine
|
|
gptkbp:formulation
|
gptkb:tablet
Injection
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Betaloc
|
|
gptkbp:indication
|
gptkb:Anxiety
Post-myocardial infarction
Migraine prophylaxis
Tachyarrhythmias
|
|
gptkbp:ingredients
|
gptkb:Metoprolol
|
|
gptkbp:interacts_with
|
gptkb:diabetes
Calcium channel blockers
Antiarrhythmic drugs
Non-steroidal anti-inflammatory drugs (NSAIDs)
|
|
gptkbp:is_involved_in
|
gptkb:children
Adults
Elderly
Pregnant women
|
|
gptkbp:is_monitored_by
|
Kidney function
Blood pressure
Heart rate
Liver function
|
|
gptkbp:legal_status
|
Prescription only
|
|
gptkbp:lifespan
|
3 to 7 hours
|
|
gptkbp:manufacturer
|
gptkb:Astra_Zeneca
|
|
gptkbp:metabolism
|
Liver
|
|
gptkbp:route_of_administration
|
Intravenous
Oral
|
|
gptkbp:side_effect
|
Dizziness
Fatigue
Bradycardia
Hypotension
|
|
gptkbp:structure
|
C15 H25 NO3
|
|
gptkbp:symptoms
|
gptkb:Tachycardia
Angina
Rebound hypertension
|
|
gptkbp:used_for
|
Heart failure
Hypertension
Angina pectoris
|
|
gptkbp:bfsParent
|
gptkb:metoprolol
|
|
gptkbp:bfsLayer
|
5
|